The New Faces of Drug Allergy
Sunday, March 5, 2017: 8:15 AM-9:45 AM
Georgia World Congress Center, Building B, Level 1, Exhibit Hall B1
1.50 CME/CE
David A. Khan , MD FAAAAI

Learning Objectives:
  1. Discuss the significant morbidity associated with inappropriate labeling of patients with penicillin allergy and review strategic methods for de-labeling penicillin allergic patients
  2. Discuss the pathophysiology of AERD and the approach to management of patients with AERD
  3. Discuss and characterize the features of hypersensitivity reactions to biologics and develop a management strategy for future administrations
8:15 AM
Appropriate Identification of Penicillin Allergy: A Critical Public Health Concern
Roland Solensky, MD FAAAAI
  • Plenary Talk (1).pdf (2.5 MB)
  • 8:45 AM
    Aspirin Exacerbated Respiratory Disease (AERD): Updates from the Bench to the Bedside
    Tanya M. Laidlaw, MD FAAAAI
    9:15 AM
    Biologics in Allergic Disease: The Other Side of the Sword
    Mariana C. Castells, MD PhD FAAAAI
    See more of: Plenary